Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
VanPelt Biosciences, LLC is a Maryland-based biotechnology company specializing in the development and manufacture of ELISA and rapid in vitro diagnostic (IVD) products. The company offers a comprehensive catalog of diagnostic kits for various infectious agents, including Epstein-Barr Virus, Cytomegalovirus, and SARS-CoV, which are widely used in clinical research. Beyond product manufacturing, VanPelt Biosciences provides custom services such as antibody and protein labeling, lateral flow assay development, and the production of high-density gold nanoparticles. The company's expertise is frequently leveraged in academic collaborations to investigate the immunological underpinnings of complex conditions like schizophrenia, depression, and Alzheimer's disease. With a history of innovation dating back to the late 1990s, VanPelt Biosciences continues to support the global research community with high-quality diagnostic tools.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on VanPelt Biosciences.